Since the cloning of OCTN1 and OCTN2 in the late 1990s, many studies have investigated their function, expression, and regulation due to their involvement in human pathologies, such as primary carnitine deficiency, inflammatory-based diseases, and cancer. Here, SLC22A5 is linked to systemic primary carnitine deficiency disease.